Qu Y - Search Results

1

Structure optimization and preliminary bioactivity evaluation of N-hydroxybenzamide-based HDAC inhibitors with Y-shaped cap.

Yu C, He F, Qu Y, Zhang Q, Lv J, Zhang X, Xu A, Miao P, Wu J. Yu C, et al. Among authors: qu y. Bioorg Med Chem. 2018 May 1;26(8):1859-1868. doi: 10.1016/j.bmc.2018.02.033. Epub 2018 Feb 18. Bioorg Med Chem. 2018. PMID: 29500131

2

Design, synthesis, and preliminary bioactivity evaluation of N¹ -hydroxyterephthalamide derivatives with indole cap as novel histone deacetylase inhibitors.

Wang X, Li X, Li J, Hou J, Qu Y, Yu C, He F, Xu W, Wu J. Wang X, et al. Among authors: qu y. Chem Biol Drug Des. 2017 Jan;89(1):38-46. doi: 10.1111/cbdd.12819. Epub 2016 Oct 26. Chem Biol Drug Des. 2017. PMID: 27416889

3

Development of Bruton's Tyrosine Kinase Inhibitors for Rheumatoid Arthritis.

Lv J, Wu J, He F, Qu Y, Zhang Q, Yu C. Lv J, et al. Among authors: qu y. Curr Med Chem. 2018;25(42):5847-5859. doi: 10.2174/0929867325666180316121951. Curr Med Chem. 2018. PMID: 29546831 Review.

4

Advances on graphene-based nanomaterials for biomedical applications.

Qu Y, He F, Yu C, Liang X, Liang D, Ma L, Zhang Q, Lv J, Wu J. Qu Y, et al. Mater Sci Eng C Mater Biol Appl. 2018 Sep 1;90:764-780. doi: 10.1016/j.msec.2018.05.018. Epub 2018 May 4. Mater Sci Eng C Mater Biol Appl. 2018. PMID: 29853147 Review.

5

Design, synthesis and activity evaluation of indole-based double - Branched HDAC1 inhibitors.

Zhang Q, Lv J, He F, Yu C, Qu Y, Zhang X, Xu A, Wu J. Zhang Q, et al. Among authors: qu y. Bioorg Med Chem. 2019 Apr 15;27(8):1595-1604. doi: 10.1016/j.bmc.2019.03.008. Epub 2019 Mar 4. Bioorg Med Chem. 2019. PMID: 30879863

6

Glycyrrhetinic acid-modified graphene oxide mediated siRNA delivery for enhanced liver-cancer targeting therapy.

Qu Y, Sun F, He F, Yu C, Lv J, Zhang Q, Liang D, Yu C, Wang J, Zhang X, Xu A, Wu J. Qu Y, et al. Eur J Pharm Sci. 2019 Nov 1;139:105036. doi: 10.1016/j.ejps.2019.105036. Epub 2019 Aug 22. Eur J Pharm Sci. 2019. PMID: 31446078

7

Design, synthesis and biological evaluation of dual-function inhibitors targeting NMDAR and HDAC for Alzheimer's disease.

He F, Ran Y, Li X, Wang D, Zhang Q, Lv J, Yu C, Qu Y, Zhang X, Xu A, Wei C, Chou CJ, Wu J. He F, et al. Among authors: qu y. Bioorg Chem. 2020 Oct;103:104109. doi: 10.1016/j.bioorg.2020.104109. Epub 2020 Jul 21. Bioorg Chem. 2020. PMID: 32768741

8

Structure-Guided Discovery of Subtype Selective SIRT6 Inhibitors with a β-Carboline Skeleton for the Treatment of Breast Cancer.

Liang C, Wang S, Feng D, Wang S, Zheng C, Qu Y, Wang W, Ma Y, Li H, Yang H, Cao H, Hua H, Cheng M, Li D. Liang C, et al. Among authors: qu y. J Med Chem. 2024 Dec 26;67(24):21975-22001. doi: 10.1021/acs.jmedchem.4c01921. Epub 2024 Dec 4. J Med Chem. 2024. PMID: 39631827

9

Discovery of 2-((3-cyanopyridin-2-yl)thio)acetamides as human lactate dehydrogenase A inhibitors to reduce the growth of MG-63 osteosarcoma cells: Virtual screening and biological validation.

Cui W, Lv W, Qu Y, Ma R, Wang YW, Xu YJ, Wu D, Chen X. Cui W, et al. Among authors: qu y. Bioorg Med Chem Lett. 2016 Aug 15;26(16):3984-7. doi: 10.1016/j.bmcl.2016.06.083. Epub 2016 Jun 30. Bioorg Med Chem Lett. 2016. PMID: 27406795

10

Synthesis and evaluation of alkoxy-substituted enamides against influenza A virus in vitro and in vivo.

Liu Z, Ge Y, Ding L, Zhang Z, Qu Y, Jin C, Wang XN, Wang Z. Liu Z, et al. Among authors: qu y. Bioorg Chem. 2023 Oct;139:106712. doi: 10.1016/j.bioorg.2023.106712. Epub 2023 Jul 4. Bioorg Chem. 2023. PMID: 37421691

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,375 results

Search Page

Filters